Creative Biolabs specializes in phage display technology for constructing and screening various peptide and protein libraries, utilizing filamentous phages to display fusion proteins. The company offers tailored biopanning strategies for library screening, including solid-phase, in-solution, cell-based, and in vivo methods. Their services target a range of applications from therapeutic and monoclonal antibody discovery to peptide function exploration across multiple species.